Medtronic reports full year and fourth quarter fiscal 2023 financial results; announces dividend increase
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- AI stocks lift Wall St as oil falls, Treasury yields decline
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- AMD stock jumps as chip rally builds ahead of summit
- Novo Nordisk shares drop as investor event disappoints
Medtronic, Inc. (MDT) PT Raised to $100 at Evercore ISI, 'we find MDT compelling in a choppy macro environment'
May 25, 2023 11:15 AM EDTEvercore ISI analyst Vijay Kumar raised the price target on Medtronic, Inc. (NYSE: MDT) to $100.00 (from $88.00) while maintaining a Outperform rating.
The analyst comments "Generally, inlinish results (vs expecs) and Guide are not reasons to be cheeringbut given the uniqueness of MDT situation, we see the 4Q print as a clearing event and time for investors to get incrementally constructive. For background, MDT has had a tough 18 months, starting with the late 2021 triple whammy of Diabetes warning letter, RDN headline miss and pushout of robotics. This... More
Deutsche Bank Keeps Hold Rating on Medtronic, Inc. (MDT), 'Good, but maybe not quite good enough'
May 25, 2023 11:13 AM EDTDeutsche Bank analyst Pito Chickering reiterated a Hold rating and $87.00 price target on Medtronic, Inc. (NYSE: MDT).
The analyst comments "Net-net. The debate heading into the quarter was simple: (1) What does 4Q results imply about guidance; (2) Is FY 2024 guidance a... More
Medtronic (MDT) Tops Q4 EPS by 2c, Beats on Revenue; Offers FY23 Guidance
May 25, 2023 6:46 AM EDTMedtronic (NYSE: MDT) reported Q4 EPS of $1.57, $0.02 better than the analyst estimate of $1.55. Revenue for the quarter came in at $8.5 billion versus the consensus estimate of $8.25 billion.
GUIDANCE:
Medtronic sees FY2024 EPS of $5.00-$5.10, versus the consensus of... More
